NMN Raw Material Manufacturer
  • Uthever
    • About Uthever
    • About NMN
  • Scientific Study
    • Preclinical Study
    • Clinical Study
    • NMN studies
  • About Effepharm
    • Company Profile
    • Research & Development
    • Scientific Advisory Board
  • News & Events
    • News
    • Events
  • Contact Us
  • Chinese Language
    • Chinese Language
Select Page

Subacute Toxicity of NMN

Subacute Toxicity of NMN

by Effepharm | Feb 18, 2021 | Company news

The administration of Nicotinamide mononucleotide(NMN) which is a key precursory metabolite of NAD+ has been reported to have remarkable therapeutic...

Hi Mrs, NMN Helps Pregnancy

Hi Mrs, NMN Helps Pregnancy

by Effepharm | Feb 2, 2021 | Company news

With the increasing, late marriage and late childbirth in China, as well as the two-child policy, and even the looming phenomenon of the third child...

NMN, A Heart Disease Terminator

NMN, A Heart Disease Terminator

by Effepharm | Jan 26, 2021 | Company news

As the engine of the human body, the heart occupies an incomparable position in the body. Obligations, however, go hand in hand with...

What are the changes NMN can visibly make on you?

What are the changes NMN can visibly make on you?

by Effepharm | Jan 19, 2021 | Company news

Since the nicotinamide mononucleotide (NMN) was found to promote the increase of NAD+ in the body, the scientific research on its anti-aging effect...

NMN Has Anti-Aging Potential for Kidneys

NMN Has Anti-Aging Potential for Kidneys

by uthever | Jan 13, 2021 | Company news

The world’s population of older adults continues to expand at an unprecedented pace. So, there is a need for a better understanding of aging...

How does NMN work in Sirtfood Diet?

How does NMN work in Sirtfood Diet?

by uthever | Jan 6, 2021 | Industry News

UTHEVERIDIA CH.7

Meet us at CPhi 2020 at Booth E5A08

Meet us at CPhi 2020 at Booth E5A08

by uthever | Dec 4, 2020 | Company news

From 16Dec to 18Dec 2020, Effepharm will attend CPhi 2020 in Shanghai, China. As an exhibitor, our booth will be E5A08 At the expo, Effepharm will...

UTHEVER®NMN AWARDED 2020 TOP 10 HOT RAW MATERIALS IN THE NUTRITION AND HEALTH INDUSTRY

UTHEVER®NMN AWARDED 2020 TOP 10 HOT RAW MATERIALS IN THE NUTRITION AND HEALTH INDUSTRY

by uthever | Nov 23, 2020 | Company news

2020 Nutrition Health Entrepreneur Conference (NHEC) was hosted in Bejing International Conference center on Nov.22nd, 2020. With the theme of...

Brief comparison between NMN cocktail therapy and mRNA vaccine

Brief comparison between NMN cocktail therapy and mRNA vaccine

by uthever | Nov 19, 2020 | Industry News

Undoubtedly, the whole world is undergoing great shock under the COVID-19 circumstance. According to some statistics, the number of deaths caused by...

Study revealed that NMN may imparts protection against Doxorubicin-induced cardiotoxicity

Study revealed that NMN may imparts protection against Doxorubicin-induced cardiotoxicity

by Effepharm | Nov 11, 2020 | Industry News

Recently, the WHO and IARC released the latest World Cancer Report, which provides a comprehensive overview of the global burden of increasing...

« Older Entries

About EffePharm

Uthever is an NMN trademark of EffePharm (Shanghai) Co., Ltd, a manufacturer, supplier and marketer of novel ingredients applied in dietary supplements, sports nutrition, pharmaceutical and food industries.

Headquarters

EffePharm (Shanghai) Co., Ltd.

Bld 4, No.1, Mid Wangdong Rd, Shanghai, 201601, China

Tel: +86 (21) 57709202
Email: [email protected]

Uthever Logo

  • Uthever™
  • Scientific Study
  • Latest news
  • Contact us

 

  • Follow
  • Follow
  • Follow

Leave A Message

     
    Disclaimer: Please note the claims made are in reference to ingredients regarding scientific reseach only. The ingredients are not intended to diagnose, treat, cure, or prevent any disease.